000 | 01506 a2200445 4500 | ||
---|---|---|---|
005 | 20250513091526.0 | ||
264 | 0 | _c19960730 | |
008 | 199607s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPrendergast, G C | |
245 | 0 | 0 |
_aResistance of a variant ras-transformed cell line to phenotypic reversion by farnesyl transferase inhibitors. _h[electronic resource] |
260 |
_bCancer research _cJun 1996 |
||
300 |
_a2626-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aActins _xmetabolism |
650 | 0 | 4 | _aAlkyl and Aryl Transferases |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCell Transformation, Neoplastic _xmetabolism |
650 | 0 | 4 |
_aCytoskeleton _xultrastructure |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aFarnesyltranstransferase |
650 | 0 | 4 |
_aGTP-Binding Proteins _xmetabolism |
650 | 0 | 4 | _aGenes, ras |
650 | 0 | 4 |
_aMembrane Proteins _xmetabolism |
650 | 0 | 4 | _aMyristates |
650 | 0 | 4 |
_aOligopeptides _xpharmacology |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aProtein Processing, Post-Translational |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aTransferases _xantagonists & inhibitors |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 | _arhoB GTP-Binding Protein |
700 | 1 | _aDavide, J P | |
700 | 1 | _aLebowitz, P F | |
700 | 1 | _aWechsler-Reya, R | |
700 | 1 | _aKohl, N E | |
773 | 0 |
_tCancer research _gvol. 56 _gno. 11 _gp. 2626-32 |
|
999 |
_c8652743 _d8652743 |